ArticleMedicine2025
Efficacy of recombinant bovine basic fibroblast growth factor gel combined with compound polymyxin B ointment on wound healing after fistulotomy.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Successful Topical Treatment of Hydroxyurea-Induced Ulcers Without Drug Discontinuation: A Case Report.Case reports in hematology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the effect of recombinant bovine basic fibroblast growth factor (rbFGF) gel combined with compound polymyxin B ointment on wound healing after fistulotomy. This retrospective cohort analysis enrolled 156 patients with simple anal fistulas who underwent fistulotomy between January 2023 and March 2024. The primary outcome was wound healing time. The secondary outcomes included wound pain and exudate scores on postoperative days 3, 7, and 14, recurrence and satisfaction rates, and anal function (Wexner score). Altogether, 156 eligible patients were analyzed, with 71 patients receiving conventional dressing changes (Group 1) and 85 patients receiving rbFGF gel combined with compound polymyxin B ointment (Group 2). The wound healing time was shorter in Group 2 than in Group 1 (P < .05). No significant differences were observed in the median wound exudate scores on postoperative days 3 and 7 between the 2 groups, but Group 2 showed lower scores on day 14 (P < .05). The pain scores were lower in Group 2 than in Group 1 at all time points (all P < .05). At the 12-month follow-up, no recurrence was reported in either group, and the postoperative Wexner scores were not significantly different between the 2 groups, but Group 2 had higher satisfaction rates (94.19% vs 84.51%, P < .05). rbFGF gel combined with compound polymyxin B ointment effectively promotes wound healing after fistulotomy, shortens healing time, and reduces postoperative pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.